CV Sciences (CVSI) Goodwill & Intangibles (2012 - 2026)
CV Sciences (CVSI) posted Goodwill & Intangibles of $1.1 million for Q1 2026, down 2.02% sequentially from $1.1 million in Q4 2025, and down 3.17% YoY from $1.1 million in Q1 2025.
CV Sciences (CVSI) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
CV Sciences has reported Goodwill & Intangibles for 15 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Goodwill & Intangibles fell 3.17% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 3.17% YoY) and the FY2025 annual result came in at $1.1 million, up 2.54% from the prior year.
- Goodwill & Intangibles slipped to $1.1 million in Q1 2026 per CVSI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $1.5 million in Q1 2022 and troughed at $251000.0 in Q4 2022.
- A 5-year average of $851000.0 and a median of $1.1 million in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles slumped 83.1% in 2022, then soared 239.84% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $251000.0 in 2022, then soared by 67.33% to $420000.0 in 2023, then surged by 153.33% to $1.1 million in 2024, then gained by 2.54% to $1.1 million in 2025, then fell by 2.02% to $1.1 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $1.1 million, $1.1 million, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 853,000.00 |
| Jun 30, 2024 | 767,000.00 |
| Mar 31, 2024 | 413,000.00 |
| Dec 31, 2023 | 420,000.00 |
| Sep 30, 2023 | 251,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 251,000.00 |
| Dec 31, 2022 | 251,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 6.52 Mn |